- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05977569
Physiological and Sensory Responses to Prolonged Fasting in Humans (PRO-FAST)
Study Overview
Status
Intervention / Treatment
Detailed Description
This study will employ a single-arm, non-randomised design in which participants will act as their own control prior to undergoing 3 days of fasting. The control phase includes 3 days of habitual energy balance assessment before coming into the laboratory for baseline meal testing with blood, muscle, and adipose samples as well as anthropometric assessment.
Participants will then be provided with a standardised lunch to be consumed around midday and a standardised dinner to be consumed at 2000 h.
Participants will then be asked to refrain from caloric intake for 3 days until they return to the laboratory for follow up measures.
Participants will be provided with monitoring equipment throughout the 3 days of fasting and will be asked to provide a blood sample at 0800 h each day alongside self recording of blood pressure, weight, and urinary ketones each day. On the middle day (day 2) participants will also be asked to come into the lab to provide a blood sample at 2000 h.
The follow up visit will be identical to that performed before the fast, including meal testing, blood, muscle, and adipose samples.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Somerset
-
Bath, Somerset, United Kingdom, BA2 7AY
- University of Bath
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Body mass index 20.0-29.9 kg∙m-2
- Age 18-45 years
- Willing to abstain from food intake for just over 3 days (~82 hours)
- Able and willing to provide informed consent and safely comply with study procedures
- Females to maintain record of regular menstrual cycle phase or contraceptive use
- No anticipated changes in lifestyle during the study (e.g. holidays or exercise programmes)
Exclusion Criteria:
• Any reported condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias
- Any diagnosed metabolic disease (e.g. type 1 or type 2 diabetes)
- Any reported use of substances which may pose undue personal risk to the participants or introduce bias into the experiment
- Pregnancy
- Breastfeeding
- Lifestyle not conforming to standard sleep-wake cycle (e.g. shift worker)
- History of eating disorders (e.g. anorexia)
- Any reported recent (<6 months) change in body mass (± 3%)
- Uncontrolled hyperthyroidism
- Advanced cerebrovascular insufficiency or dementia
- Advanced liver or kidney insufficiency
- History of migraine and or headache
- Psychotic disorders
- Unstable or severe coronary artery disease
- Retinal detachment
- Duodenal or stomach ulcer
- Cancer and malignant disease
- Regular use of Non-steroidal anti-inflammatory drugs (NSAIDs)
- Use of Systemic corticoids
- Use of Antihypertensives (especially beta-blockers and diuretics)
- Use of Antidiabetics
- Use of Anti-coagulants
- Use of Psychotropics (especially neuroleptics and lithium)
- Use of Anticonvulsants.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prolonged Fasting
All participants are asked to act as their own control prior to being asked to undergo 3 days of fasting.
|
Participants are asked to refrain from caloric intake for 3 days following a period of habitual lifestyle assessment and metabolic assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in postprandial insulin responses
Time Frame: 3 days
|
Change in postprandial insulin (mmol/L) response to a standardised meal before and after 3 days of fasting.
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in circulating glycerol and non-esterified fatty acids
Time Frame: 1 day, 2 days, 3 days
|
Change in indices of lipolysis from adipose tissue in response to prolonged fasting (Glycerol mmol/L; NEFA mmol/L)
|
1 day, 2 days, 3 days
|
|
Change in Autophagy
Time Frame: 3 days
|
Change in autophagic flux in response to prolonged fasting, assessed in skeletal muscle and circulating neutrophils.
|
3 days
|
|
Change in plasma lactate
Time Frame: 1 day, 2 days, 3 days
|
Change in plasma lactate in response to prolonged fasting (indices of Cori cycle)
|
1 day, 2 days, 3 days
|
|
Change in plasma pyruvate
Time Frame: 1 day, 2 days, 3 days
|
Change in plasma pyruvate in response to prolonged fasting (indices of Cori cycle)
|
1 day, 2 days, 3 days
|
|
Change in ketosis.
Time Frame: 1 day, 2 days, 3 days.
|
Change in urinary (acetoacetate) ketones in response to prolonged fasting.
|
1 day, 2 days, 3 days.
|
|
Change in ketosis.
Time Frame: 1 day, 2 days, 3 days.
|
Change in circulating (beta-hydroxybutyrate) ketones in response to prolonged fasting.
|
1 day, 2 days, 3 days.
|
|
Change in body mass
Time Frame: 1 day, 2 days, 3 days.
|
Change in body mass, pre-post, and during the prolonged fast.
|
1 day, 2 days, 3 days.
|
|
Change in blood pressure
Time Frame: 1 day, 2 days, 3 days.
|
Change in blood pressure pre-, post-, and during the prolonged fast
|
1 day, 2 days, 3 days.
|
|
Change in interstitial fluid glucose concentrations
Time Frame: 1 day, 2 days, 3 days.
|
Change in interstitial fluid glucose concentrations pre-, post-, and during the prolonged fast (assessed via continual glucose monitoring)
|
1 day, 2 days, 3 days.
|
|
Change in amino acid metabolism
Time Frame: 3 days.
|
Change in amino acid metabolism (i.e.
BCAAs and ketoacids) in skeletal muscle
|
3 days.
|
|
Change in amino acid metabolism
Time Frame: 3 days.
|
Change in amino acid metabolism (i.e.
BCAAs and ketoacids) in adipose tissue
|
3 days.
|
|
Change in amino acid metabolism
Time Frame: 3 days.
|
Change in amino acid metabolism (i.e.
BCAAs and ketoacids) in circulation
|
3 days.
|
|
Change in postprandial glucose responses.
Time Frame: 3 days.
|
Change in postprandial glucose (mmol/L) response to a standardised meal before and after 3 days of fasting.
|
3 days.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adiposity
-
Johns Hopkins UniversityCompleted
-
University Hospital, BrestCompleted
-
Neothetics, IncCompletedSubcutaneous Abdominal AdiposityUnited States
-
University of SharjahAl Jalila FoundationCompleted
-
University Hospital, Basel, SwitzerlandRigshospitalet, DenmarkCompletedAdipositySwitzerland
-
University of Colorado, DenverNational Institute on Aging (NIA)RecruitingMenopause | Aging | Adiposity | Estrogen DeficiencyUnited States
-
Pennington Biomedical Research CenterLouisiana Clinical and Translational Science CenterTerminatedAdiposity | Menopause Surgical | Estrogen DeficiencyUnited States
-
University of Southern CaliforniaTerminatedAdiposity | Obesity, AbdominalUnited States
-
Fudan UniversityInner Mongolia Yili Industrial Group Co., LtdCompletedObesity | AdiposityChina
-
Massachusetts General HospitalCompletedAdiposityUnited States
Clinical Trials on Prolonged Fasting
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationTerminatedFertility Issues | Fertility Disorders | IVF | Sub Fertility, Female | Sub-fertilityGermany
-
Leiden University Medical CenterCentre for Medical Systems BiologyCompletedNutrient Sensing During a Prolonged FastNetherlands
-
Université de SherbrookeCentre de recherche du CHU de SherbrookeCompleted
-
University of MinnesotaNot yet recruiting
-
Shanghai University of Traditional Chinese MedicineUnknown
-
Wageningen UniversityCompletedFasting | Clinical Trial | Lipid Metabolism | Adipose TissueNetherlands
-
Charite University, Berlin, GermanyActive, not recruitingRheumatoid Arthritis | Osteoarthritis, Knee | Metabolic Syndrome | Fibromyalgia | Osteoarthritis, HipGermany
-
Arizona State UniversityTerminated
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedMultiple Myeloma | Weight Loss | Fasting | MGUS | Cancer Prevention | Smoldering Waldenstrom Macroglobulinemia(WM)United States
-
Memorial Sloan Kettering Cancer CenterRockefeller UniversityActive, not recruitingChildhood Cancer SurvivorsUnited States